Stock HIMS HIMS & HERS HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
19.42 USD -4.66% Intraday chart for Hims & Hers Health, Inc. +15.05% +118.20%
May. 29 Social Buzz: Wallstreetbets Stocks Mostly Lower Pre-Bell Wednesday; CAVA Group, Hims & Hers Health to Decline MT
May. 22 Hims & Hers Health Insider Bought Shares Worth $1,951,763, According to a Recent SEC Filing MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's profit outlook over the next few years is a strong asset.
  • The company is in a robust financial situation considering its net cash and margin position.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company does not generate enough profits, which is an alarming weak point.
  • With an expected P/E ratio at 125.45 and 69.07 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
HIMS & HERS HEALTH, INC. Stock Hims & Hers Health, Inc.
+118.20% 4.17B -
TELADOC HEALTH, INC. Stock Teladoc Health, Inc.
-47.84% 1.91B
D+
QDM INTERNATIONAL INC. Stock QDM International Inc.
+78.57% 584M - -
TALKSPACE, INC. Stock Talkspace, Inc.
+3.15% 445M -
AMERICAN WELL CORPORATION Stock American Well Corporation
-71.35% 127M
C-
SHL TELEMEDICINE LTD. Stock SHL Telemedicine Ltd.
-25.18% 94.34M -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HIMS Stock
  4. Ratings Hims & Hers Health, Inc.